Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05525962

Vulnerability/Resilience Factors Influencing the Developmental Trajectories and Adaptive Methods of Children and Adolescents in Child Welfare System.

Assess the prevalence of medico-psychological characteristics at the time of placement (M0), their appearance / disappearance and during the two years following placement (M12 and M24) by age group in children / adolescents in Child Protective Services and placed full-time in the structures of Seine-Maritime and Eure as well as in nursery in Le Havre or Rouen

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Behavior, Child Adolescent - Emotional Problem Adolescent Behavior Adolescent Development Behavior Child Behavior Child Behavior Disorders Child Development Child Development Disorder Child Mental Disorder Developmental Disabilities Mental Disorders Neurodevelopmental Disorders

Age range

Up to 16 year

Sex eligibility

All sexes

Study type

Observational

Primary location

IDEFHI, Canteleu, France

Loading trial locations.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Minor adressed to child protective services
  • Minor placed full time

Exclusion criteria

  • Non affiliation to social security system
  • Non accompanied minor
  • Minor and/or parfents not understanding french
  • Minor informed and refused participation
  • Parents or tutor having refused participation of their child

Treatment and study plan

questionnaries, scales, cognitive tests

Behavioral

A first interview is planned with a psycholgist in the weeks following the minor arrival in the structure (M0)

  • M0: cognitive test, psychiatric classification and psychologic assessments
  • M12 and M24: psychiatric classification and psychologic assessments

Primary outcomes

  1. Presence and nature of psychiatric disorders according to DSM 5

    Time frame: At inclusion

    assessed by MINI S-KID (International Neuropsychiatric Interview for Children and Adolescents) for 6-18 year olds and DC 0-5 (Diagnostic Classification from 0 to 5 ) for 0 to 5 year olds.

  2. Presence and nature of psychiatric disorders according to DSM 5

    Time frame: 1 year after inclusion

    assessed by MINI S-KID (International Neuropsychiatric Interview for Children and Adolescents) for 6-18 year olds and DC 0-5 (Diagnostic Classification from 0 to 5 ) for 0 to 5 year olds.

  3. Presence and nature of psychiatric disorders according to DSM 5

    Time frame: After 2 years

    assessed by MINI S-KID (International Neuropsychiatric Interview for Children and Adolescents) for 6-18 year olds and DC 0-5 (Diagnostic Classification from 0 to 5 ) for 0 to 5 year olds.

Secondary outcomes

  1. Description of cognitive abilities

    Time frame: At inclusion

    0 to 2 years old : BAYLEY V3 or Brunet Lezine (revised) 3 to 6 years old : WPPSI-IV 7 to 16 years old : WISC-V 16 to 18 years old : WAIS-V

  2. Presence of an attachement psychopathological disorder

    Time frame: At inclusion

    Assessed by the strange situation procedure for participants aged from 9 months old to 3 years old Assessed by Attachment story completion test from 4 to 9 years old Assessed by the Inventory of Parents and Peer Attachement from 10 to 18 years old

  3. Presence of a Borderline-Personality-Disorder

    Time frame: At inclusion

    Using AbDIB questionnaire from 12 to 18 years old

  4. Presence of an emotional and behavioral; self-regulation Disorder

    Time frame: At inclusion

    • 1.5 -18 ans : Child Behavior Checklist (CBCL)

  5. Presence of an emotional and behavioral; self-regulation Disorder

    Time frame: At inclusion

    • 6-18 ans : Affective Reactivity Index Child Report and Parent Report (ARI)

  6. Presence of an emotional and behavioral; self-regulation Disorder

    Time frame: At inclusion

    • 9-18 ans: Toronto Alexithymia Scale (TAS-20)

  7. Presence of an emotional and behavioral; self-regulation Disorder

    Time frame: At inclusion

    • 6-18 ans : Rosenberg self-assessment scale - (RSE)

  8. Presence of one or multisensory hallucinations

    Time frame: At inclusion

    6 -18 ans: Multisensory Hallucinations Scale for Children (MHASC)

  9. Mentalization capacities

    Time frame: At inclusion

    12 to 18 using the Reflective Functioning Questionnaire (RFQ 20)

  10. Presence of eating disorder

    Time frame: At inclusion

    2 -18 : SCOFF questionnaire

  11. Substance use disorders

    Time frame: At inclusion

    11 to 18 years old using the Detection of alcohol and drugs problems in adolescent (DepAdo)

  12. Analyses of adverse life events

    Time frame: At inclusion

    • UCLA Child/Adolescent PTSD Reaction Index (PTSD-UCLA)

  13. Analyses of adverse life events

    Time frame: At inclusion

    • 11 - 18 years old: Childhood Trauma Questionnaire (CTQ)

  14. Description of care pathway

    Time frame: At inclusion

    using a socio-demographic report (scolarship, medical care and environnement)

  15. Coping strategies

    Time frame: At inclusion

    • 12 to 18 years old using the Adolescent Coping Scale (ACS)

  16. Coping strategies

    Time frame: At inclusion

    • 7 to 13 years old : Self-Report Coping Scale (SRCS)

  17. Coping strategies

    Time frame: After 1 year

    • 12 to 18 years old using the Adolescent Coping Scale (ACS)

  18. Coping strategies

    Time frame: After 1 year

    • 7 to 13 years old : Self-Report Coping Scale (SRCS)

  19. Coping strategies

    Time frame: After 2 years

    • 12 to 18 years old using the Adolescent Coping Scale (ACS)

  20. Coping strategies

    Time frame: After 2 years

    • 7 to 13 years old : Self-Report Coping Scale (SRCS)

  21. Presence of depressive symptoms

    Time frame: At inclusion

    12-18 years old: Columbia-Suicide Severity Rating Scale (C-SSRS)

  22. Analyses of global functionning

    Time frame: At inclusion

    Using the global assessment functionning

  23. Analyses of global functionning

    Time frame: At inclusion

    Using Ages & Stages Questionnaires Version 3 (ASQ3)

  24. Presence of attachement psychopathological disorder

    Time frame: 1 year after inclusion

    Assessed by the strange situation procedure for participants aged from 9 months old to 3 years old Assessed by Attachment story completion test from 4 to 9 years old Assessed by the Inventory of Parents and Peer Attachement from 10 to 18 years old

  25. Presence of a Borderline-Personality-Disorder

    Time frame: After 1 year

    Using AbDIB questionnaire from 12 to 18 years old

  26. Presence of Emotional and behavioral, self-regulation Disorder

    Time frame: 1 year after inclusion

    • 1.5 -18 ans : Child Behavior Checklist (CBCL)

  27. Presence of Emotional and behavioral, self-regulation Disorder

    Time frame: 1 year after inclusion

    • 6-18 ans : Affective Reactivity Index Child Report and Parent Report (ARI)

  28. Presence of Emotional and behavioral, self-regulation Disorder

    Time frame: 1 year after inclusion

    • 9-18 ans: Toronto Alexithymia Scale (TAS-20)

  29. Presence of Emotional and behavioral, self-regulation Disorder

    Time frame: 1 year after inclusion

    • 6-18 ans : Rosenberg self-assessment scale - (RSE)

  30. Presence of one or multisensory hallucinations

    Time frame: 1 year after inclusion

    6 -18 ans: Multisensory Hallucinations Scale for Children (MHASC)

  31. Mentalization capacities

    Time frame: 1 year after inclusion

    12 to 18 years old using the Reflective Functioning Questionnaire (RFQ 20)

  32. Presence of eating disorder

    Time frame: 1 year after inclusion

    2 -18 : SCOFF questionnaire

  33. Substance use disorders

    Time frame: 1 year after inclusion

    11 to 18 years old using the Detection of alcohol and drugs problems in adolescent (DepAdo)

  34. Analyses of adverse life events

    Time frame: 1 year after inclusion

    • UCLA Child/Adolescent PTSD Reaction Index (PTSD-UCLA)

  35. Analyses of adverse life events

    Time frame: 1 year after inclusion

    • 11 - 18 years old: Childhood Trauma Questionnaire (CTQ)

  36. Description of care pathway

    Time frame: 1 year after inclusion

    using a socio-demographic report (scolarship, medical care and environnement)

  37. Presence of depressive symptoms

    Time frame: 1 year after inclusion

    12-18 years old: Columbia-Suicide Severity Rating Scale (C-SSRS)

  38. Analyses of global functionning

    Time frame: 1 year after inclusion

    Using the global assessment functionning and the Ages & Stages Questionnaires Version 3 (ASQ3)

  39. Presence of a attachement psychopathological disorder

    Time frame: 2 years after inclusion

    Assessed by the strange situation procedure for participants aged from 9 months old to 3 years old Assessed by Attachment story completion test from 4 to 9 years old Assessed by the Inventory of Parents and Peer Attachement from 10 to 18 years old

  40. Presence of a Borderline-Personality-Disorder

    Time frame: 2 years after inclusion

    Using AbDIB questionnaire from 12 to 18 years old

  41. Presence of a Emotional and behavioral self-regulation Disorder

    Time frame: 2 years after inclusion

    • 1.5 -18 ans : Child Behavior Checklist (CBCL)

  42. Presence of a Emotional and behavioral self-regulation Disorder

    Time frame: 2 years after inclusion

    • 6-18 ans : Affective Reactivity Index Child Report and Parent Report (ARI)

  43. Presence of a Emotional and behavioral self-regulation Disorder

    Time frame: 2 years after inclusion

    • 9-18 ans: Toronto Alexithymia Scale (TAS-20)

  44. Presence of a Emotional and behavioral self-regulation Disorder

    Time frame: 2 years after inclusion

    • 6-18 ans : Rosenberg self-assessment scale - (RSE)

  45. Presence of one or multisensory hallucinations

    Time frame: 2 years after inclusion

    • 6 -18 ans: Multisensory Hallucinations Scale for Children (MHASC)

  46. Mentalization capacities

    Time frame: 2 years after inclusion

    12 to 18 years old using the Reflective Functioning Questionnaire (RFQ 20)

  47. Presence of eating disorder

    Time frame: 2 years after inclusion

    2 -18 : SCOFF questionnaire

  48. Substance use disorders

    Time frame: 2 years after inclusion

    11 to 18 years old using the Detection of alcohol and drugs problems in adolescent (DepAdo)

  49. Analyses of adverse life events

    Time frame: 2 years after inclusion

    • UCLA Child/Adolescent PTSD Reaction Index (PTSD-UCLA)

  50. Analyses of adverse life events

    Time frame: 2 years after inclusion

    • 11 - 18 years old: Childhood Trauma Questionnaire (CTQ)

  51. Analyses of global functionning

    Time frame: 2 years after inclusion

    Using the global assessment functionning

  52. Analyses of global functionning

    Time frame: 2 years after inclusion

    Using the Ages & Stages Questionnaires Version 3 (ASQ3)

  53. Description of care pathway

    Time frame: 2 years after inclusion

    using a socio-demographic report (scolarship, medical care and environnement)

  54. Presence of depressive symptoms

    Time frame: 2 years after inclusion

    12-18 years old: Columbia-Suicide Severity Rating Scale (C-SSRS)

Study contacts

Contact information is provided by the study sponsor or research team.

Cécile Pourcher

CONTACT

[email protected]

02 32 88 82 65 ext. 60892

Priscille GERARDIN

CONTACT

Sponsors and collaborators

Lead sponsor

University Hospital, Rouen

Other

Registry information

Official study title

Facteurs de vulnérabilité/résilience influençant Les Trajectoires développementales et Les modalités Adaptatives d'Enfants et d'Adolescents confiés à l'Aide Sociale à l'Enfance. Cohorte Primo-arrivants.

Acronym: EvolASE-PEA

Important dates

Study start
2022
Primary completion
2027
Study completion
2027
First posted
Sep 2, 2022
Registry last updated
Apr 9, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.